Drawing for CROMA MIDFACE VOLUME DEFICIT SEVERITY SCALE (MVDSS)

USPTO serial 79268988

CROMA MIDFACE VOLUME DEFICIT SEVERITY SCALE (MVDSS)

Reviewed by CopyMark Law Group

Reg. 6132566Status 700Renewal
Filing date
Status date
Registration date
Aug 25, 2020
Examiner
MESSICK, TABITHA LEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CROMA MIDFACE VOLUME DEFICIT SEVERITY SCALE (MVDSS)?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paul D. Bianco

Paul D. Bianco Fleit Intellectual Property Law21355 East Dixie HighwaySuite 115Miami, FL 33180

Goods and services

ClassDescriptionStatusFirst use
035Advertising, marketing and promotion services; advertising services relating to pharmaceutical productsACTIVE—
041Organisation of educational conferences, educational exhibitions and organization of competitions in the field of aesthetic dermatological medicine; arrangement of conferences for educational purposes; arranging of seminars in the field of aesthetic dermatological medicine; conducting seminars in the field of aesthetic dermatological medicine; arranging of educational conferences; arranging and conducting of aesthetic dermatological medicine educational conferencesACTIVE—
042Pharmaceutical research services; medical research services; clinical research in the field of aesthetic dermatological medicine; consultancy relating to research and development in the field of therapeutics; research and development for the pharmaceutical industry in the field of aesthetic dermatological medicine; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; pharmaceutical product evaluation; development of testing methods of the effectiveness of aesthetic dermatological treatment; product testing; scientific laboratory servicesACTIVE—
044Consultancy relating to health care in the field of aesthetic dermatological medicine; health care consultancy services, namely, medical consultation and health counseling in the field of aesthetic dermatological medicine; health counseling; medical reporting services and medical information services, namely, preparation of reports relating to health care mattersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 13, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 22, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 22, 2020XXCRGENERIC MADRID TRANSACTION CREATED—
Nov 25, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 25, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 12, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jun 9, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 9, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 27, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 20, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 5, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 5, 2020XAECEXAMINER'S AMENDMENT ENTERED—
May 5, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 5, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
May 5, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
May 4, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 3, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 3, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 15, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 15, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 15, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 22, 2019RFNTREFUSAL PROCESSED BY IB—
Nov 3, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 2, 2019RFRRREFUSAL PROCESSED BY MPU—
Oct 17, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 16, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 11, 2019DOCKASSIGNED TO EXAMINER—
Oct 11, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance